Single antigen detects both immunoglobulin M (IgM) and IgG antibodies elicited by all four dengue virus serotypes

Clinical and Vaccine Immunology

Volumn 14, Issue 11, 2007, Pages 1505-1514

  Hapugoda, Menaka D ^a   Batra, Gaurav ^a   Abeyewickreme, W ^b   Swaminathan, S ^a   Khanna, N ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b UNIVERSITY OF KELANIYA   (Sri Lanka)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE DOMAIN III ANTIGEN; HEMAGGLUTINATION INHIBITING ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANALYTIC METHOD; ANTIBODY DETECTION; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DENGUE VIRUS; DIAGNOSTIC PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; SENSITIVITY AND SPECIFICITY; SEROTYPE; VIRUS CULTURE;

ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 37349119683     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00145-07     Document Type: Article

References (44)

1. AnandaRao, R., S. Swaminathan, S. Fernando, A. M. Jana, and N. Khanna. 2006. A recombinant multiepitope protein for the early detection of dengue infections. Clin. Vaccine Immunol. 13:59-67.
2. AnandaRao, R., S. Swaminathan, S. Fernando, A. M. Jana, and N. Khanna. 2005. A custom-designed recombinant multiepitope protein as a dengue diagnostic reagent. Protein Expr. Purif. 41:136-141.
3. Beasley, D. W. C., M. R. Holbrook, A. P. A. Travassos da Rosa, L. Coffey, A.-S. Carrara, K. Phillippi-Falkenstein, R. P. Bohm, Jr., M. S. Ratterree, K. M. Lillibridge, G. V. Ludwig, J. Estrada-Franco, S. C. Weaver, R. B. Tesh, R. E. Shone, and A. D. T. Barrett. 2004. Use of a recombinant envelope protein subunit antigen for specific serological diagnosis of West Nile virus infection. J. Clin. Microbiol. 42:2759-2765.
4. Bhardwaj, S., M. Holbrook, R. E. Shope, A. D. T. Barrett, and S. J. Watowich. 2001. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J. Virol. 75:4002-4007.
5. Bundo, K., and A. Igarashi. 1985. Antibody capture ELISA for detection of immunoglobulin M antibodies in sera from Japanese encephalitis and dengue hemorrhagic fever patients. J. Virol. Methods 11:15-22.
6. Burke, D. S., and T. P. Monath. 2001. Flaviviruses, p. 1043-1125. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
7. Chadwick, D., B. Arch, A. Wilder-Smith, and N. Paton. 2006. Distinguishing dengue fever from other infections on the basis of simple clinical and laboratory features: application of logistic regression analysis. J. Clin. Virol. 35:147-153.
8. Chen, Y., T. Maguire, R. E. Hileman, J. R. Fromm, J. D. Esko, R. J. Linhardt, and R. M. Marks. 1997. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:866-871.
9. Crill, W. D., and J. T. Roehrig. 2001. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75:7769-7773.
10. Cuzzubbo, A. J., T. P. Endy, A. Nisalak, S. Kalyanarooj, D. W. Vaughn, S. A. Ogata, D. E. Clements, and P. L. Devine. 2001. Use of recombinant envelope proteins for serological diagnosis of dengue virus infection in an immunochromatographic assay. Clin. Diagn. Lab. Immunol. 8:1150-1155.
11. George, R., and L. C. S. Lum. 1997. Clinical spectrum of dengue infection, p. 89-113. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, Wallingford, United Kingdom.
12. Gibbons, R. V., and D. W. Vaughn. 2002. Dengue: an escalating problem. Br. Med. J. 324:1563-1566.
13. Groen, J., P. Koraka, J. Velzing, C. Copra, and A. D. M. E. Osterhaus. 2000. Evaluation of six immunoassays for detection of dengue virus-specific immunoglobulin M and G antibodies. Clin. Diagn. Lab. Immunol. 7:867-871.
14. Gubler, D. J. 1998. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11:480-496.
15. Gubler, D. J. 2004. Cities spawn epidemic dengue viruses. Nat. Med. 10:129-130.
16. Guha-Sapir, D., and B. Schimmer. 2005. Dengue fever: new paradigms for a changing epidemiology. Emerg. Themes Epidemiol. 2:1-10.
17. Guzmán, M. G., and G. Kouri. 2002. Dengue: an update. Lancet Infect. Dis. 2:33-42.
18. Hung, J.-J., M.-T. Hsieh, M.-J. Young, C.-L. Kao, C.-C. King, and W. Chang. 2004. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J. Virol. 78:378-388.
19. Ibrahim, F., M. N. Taib, W. A. B. Wan Abas, C. C. Guan, and S. Sulaiman. 2005. A novel dengue fever (DF) and dengue haemorrhagic fever (DHF) analysis using artificial neural network (ANN). Comput. Methods Programs Biomed. 79:273-281.
20. Igarashi, A. 1997. Impact of dengue virus infection and its control. FEMS Immunol. Med. Microbiol. 18:291-300.
21. Innis, B. L. 1997. Antibody responses to dengue virus infection, p. 221-243. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, Wallingford, United Kingdom.
22. Jaiswal, S., N. Khanna, and S. Swaminathan. 2004. High-level expression and one-step purification of recombinant dengue virus type 2 envelope domain III protein in Escherichia coli. Protein Expr. Purif. 33:80-91.
23. Kao, C.-L., C.-C. King, D.-Y. Chao, H.-L. Wu, and G.-J. J. Chang. 2005. Laboratory diagnosis of dengue virus infection: current and future perspectives in clinical diagnosis and public health. J. Microbiol. Immunol. Infect. 38:5-16.
24. Khanam, S., B. Etemad, N. Khanna, and S. Swaminathan. 2006. A bivalent antigen composed of linked envelope domains III of two dengue virus serotypes elicits neutralizing antibodies specific to both constituent serotypes. Am. J. Trop. Med. Hyg. 74:266-277.
25. Khanam, S., P. Rajendra, N. Khanna, and S. Swaminathan. 2007. An adenovirus prime/plasmid boost strategy for induction of equipotent immune responses to two dengue virus serotypes. BMC Biotechnol. 7:10.
26. Khanam, S., N. Khanna, and S. Swaminathan. 2006. Induction of antibodies and T cell responses by dengue virus type 2 envelope domain III encoded by plasmid and adenoviral vectors. Vaccine 24:6513-6525.
27. Kuhn, R. J., W. Zhang, M. G. Rossman, S. V. Pletnev, J. Corver, E. Lenches, C. T. Jones, S. Mukhopadhyay, P. R. Chipman, E. G. Strauss, T. S. Baker, and J. H. Strauss. 2002. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 108:717-725.
28. Lam, S. K., and P. L. Devine. 1998. Evaluation of capture ELISA and rapid immunochromatographic test for the determination of IgM and IgG antibodies produced during dengue infection. Clin. Diagn. Virol. 10:75-81.
29. Lanciotti, R. S., C. H. Calisher, D. J. Gubler, G.-J. Chang, and A. V. Vorndam. 1992. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J. Clin. Microbiol. 30:545-551.
30. Lemmer, K., O. D. Mantke, H. G. Bae, J. Groen, C. Drosten, and M. Niedrig. 2004. External quality control assessment in PCR diagnostics of dengue virus infections, J. Clin. Virol. 30:291-296.
31. Lien, K.-Y., W.-C. Lee, H.-Y. Lei, and G.-B. Lee. 2007. Integrated reverse transcription polymerase chain reaction systems for virus detection. Biosens. Bioelectron. 22:1739-1748.
32. Lindenbach, B. D., and C. M. Rice. 2001. Flaviviridae: the viruses and their replication, p. 991-1041. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
33. Ludolfs, D., S. Schilling, J. Altenschmidt, and H. Schmitz. 2002. Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens. J. Clin. Microbiol. 40:4317-4320.
34. Mégret, F., J. P. Hugnot, A. Falconar, M. K. Gentry, D. M. Morens, J. M. Murray, J. J. Schlesinger, P. J. Wright, P. Young, M. H. V. van Regenmortel, and V. Deubel. 1992. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue envelope glycoprotein. Virology 187:480-491.
35. Rigau-Perez, J. G., G. G. Clark, D. J. Gubler, P. Reiter, E. J. Sanders, and A. V. Vorndam. 1998. Dengue and dengue haemorrhagic fever. Lancet 352:971-977.
36. Robinson, C. R., and R. T. Sauer. 1998. Optimizing the stability of single-chain proteins by linker length and composition mutagenesis. Proc. Natl. Acad. Sci. USA 95:5929-5934.
37. Roehrig, J. T., R. A. Bolin, and R. G. Kelly. 1998. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Virology 246:317-328.
38. Roehrig, J. T., A. J. Johnson, A. R. Hunt, R. A. Bolin, and M. C. Chu. 1990. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology 177:668-675.
39. Shu, P.-Y., and J.-H. Huang. 2004. Current advances in dengue diagnosis. Clin. Diagn. Lab. Immunol. 11:642-650.
40. Simmons, M., K. R. Porter, J. Escamilla, R. Graham, D. M. Watts, K. H. Eckels, and C. G. Hayes. 1998. Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies. Am. J. Trop. Med. Hyg. 58:144-151.
41. Vaughn, D. W., S. Greene, S. Kalayanarooj, B. L. Innis, S. Nimmannitya, S. Suntayakorn, A. L. Rothman, F. A. Ennis, and A. Nisalak. 1997. Dengue in the early febrile phase: viremia and antibody responses. J. Infect. Dis. 176:322-330.
42. Vorndam, V., and G. Kuno. 1997. Laboratory diagnosis of dengue virus infections, p. 313-333. In D. J. Gubler and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CAB International, Wallingford, United Kingdom.
43. World Health Organization. 1997. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control, 2nd ed. World Health Organization, Geneva, Switzerland.
44. Zhang, Y., J. T. Bahns, Q. Jin, R. Divan, and L. Chen. 2006. Toward the detection of single virus particle in serum. Anal. Biochem. 356:161-170.